Monthly
US$200
Billed every month
Sign in to subscribeAmbroxol Hydrochloride Oral Solution
As of 13 November 2026, for Ambroxol Hydrochloride Oral Solution, 46 applications are listed as under review at China's CDE; 12 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 0 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 11 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders0View records ↓
Under-review filings46View records ↓
This year’s generic filers12View records ↓
NHSA approval numbers103View records ↓
API companies with A status25View records ↓
Chemical-drug catalogue
Loaded records: 0 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | ||||||
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 103 distinct approval numbers and 66 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Han Mei Medicines Co., Ltd. romanized | 国药准字H20073956 | 3mg/ml | Category B | XR05CBA198X001010100041 | NHSA |
| Beijing Jiu Long Pharmaceutical Co., Ltd. romanized | 国药准字H20133016 | 100ml:0.6g | Category B | XR05CBA198X001010100067 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010100151 | NHSA |
| Guangdong Zhong Sheng Pharma Co., Ltd. romanized | 国药准字H20256278 | 10ml∶30mg | Category B | XR05CBA198X001010100371 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Pharmaceutical Co., Ltd. romanized | 国药准字H20243069 | See source | Category B | XR05CBA198X001010100430 | NHSA |
| Guo Yao Group Shan Tou Jin Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20163280 | 100ml:0.3g | Category B | XR05CBA198X001010100480 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20073744 | 0.3g/100ml | Category B | XR05CBA198X001010100555 | NHSA |
| Shanghai Bo Lin Ge Yin Ge Han Pharma Co., Ltd. romanized | 国药准字H20031314 | 100ml:0.6g | Category B | XR05CBA198X001010100638 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001010100801 | NHSA |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000661 | 0.6% | Category B | XR05CBA198X001010101389 | NHSA |
| Jiangsu Chen Pai Pharma Group Co., Ltd. romanized | 国药准字H20253899 | See source | Category B | XR05CBA198X001010101427 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001010101442 | NHSA |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H19980178 | 100ml:0.3g | Category B | XR05CBA198X001010101445 | NHSA |
| Su Zhong Pharma Group Co., Ltd. romanized | 国药准字H20143034 | See source | Category B | XR05CBA198X001010101493 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20233006 | 100ml:0.3g | Category B | XR05CBA198X001010101503 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010101564 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001010101740 | NHSA |
| Sichuan Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20073944 | 100ml:0.3g | Category B | XR05CBA198X001010102132 | NHSA |
| Sichuan Jian Neng Pharmaceutical Co., Ltd. romanized | 国药准字H20143384 | 100ml:0.3g(0.3%) | Category B | XR05CBA198X001010102166 | NHSA |
| Shandong Lu Kang Hao Li You Bio Technology Kai Fa Co., Ltd. romanized | 国药准字H20244122 | 100ml:0.6g | Category B | XR05CBA198X001010102357 | NHSA |
| Shaanxi Xi Yue Pharmaceutical Co., Ltd. romanized | 国药准字H20263410 | 100ml :0.6g | Category B | XR05CBA198X001010102439 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001010102601 | NHSA |
| Le Sheng Pharma Shijiazhuang Co., Ltd. romanized | 国药准字H20084175 | 100ml:0.3g | Category B | XR05CBA198X001010102680 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001010102777 | NHSA |
| Hua Run San Jiu (Tang Shan) Pharma Co., Ltd. romanized | 国药准字H20065542 | 5ml:15mg | Category B | XR05CBA198X001010102778 | NHSA |
| Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized | 国药准字H20263219 | 10ml:60mg | Category B | XR05CBA198X001010103004 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20083980 | 100ml:0.6g | Category B | XR05CBA198X001010103204 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001010103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001010103658 | NHSA |
| Ha Yao Group San Jing Pharmaceutical Co., Ltd. romanized | 国药准字H20184033 | 10ml:30mg | Category B | XR05CBA198X001010103705 | NHSA |
| Heilongjiang Ao Li Da Nai De Pharmaceutical Co., Ltd. romanized | 国药准字H20254579 | 100ml:0.6g | Category B | XR05CBA198X001010103719 | NHSA |
| Heilongjiang Zhen Bao Dao Pharma Co., Ltd. romanized | 国药准字H20233460 | 100ml:0.6g | Category B | XR05CBA198X001010103783 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001010103804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001010104193 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010104363 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001010104434 | NHSA |
| Zhejiang Kang En Bei Zhong Yao Co., Ltd. romanized | 国药准字H20203287 | 100ml:0.3g | Category B | XR05CBA198X001010104750 | NHSA |
| Wan Yuan (Fuzhou) Pharma Co., Ltd. romanized | 国药准字H20093979 | 100ml:0.6g | Category B | XR05CBA198X001010104855 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20244619 | See source | Category B | XR05CBA198X001010104942 | NHSA |
| Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized | 国药准字H20264703 | 100ml:0.3g | Category B | XR05CBA198X001010104960 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001010105038 | NHSA |
| Hua Run San Jiu (Nanchang) Pharma Co., Ltd. romanized | 国药准字H20103009 | See source | Category B | XR05CBA198X001010105342 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20244718 | 5ml:30mg | Category B | XR05CBA198X001010105356 | NHSA |
| Jiang Zhong Pharma Co., Ltd. romanized | 国药准字H20073939 | 100ml:0.3g | Category B | XR05CBA198X001010105394 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20264447 | 250ml:0.75g | Category B | XR05CBA198X001010105816 | NHSA |
| Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | 国药准字H20264028 | 100ml:0.3g | Category B | XR05CBA198X001010106673 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20223724 | 100ml:0.3g | Category B | XR05CBA198X001010110349 | NHSA |
| A. Nattermann & Cie. GmbH | 国药准字HJ20250024 | 100ml∶0.3g | Category B | XR05CBA198X001010178179 | NHSA |
| Ao Mei Pharmaceutical Factory romanized | 国药准字HC20170011 | 10ml:30mg | Category B | XR05CBA198X001010179136 | NHSA |
| Chengdu Hui De Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20223584 | 100ml:0.3g | Category B | XR05CBA198X001010181591 | NHSA |
| Jiangsu Su Zhong Pharma Group Biopharmaceutical Co., Ltd. romanized | 国药准字H20255824 | 100ml:0.3g | Category B | XR05CBA198X001010181821 | NHSA |
| Hainan Feng Kai Si Pharmaceutical Co., Ltd. romanized | 国药准字H20233005 | 100ml:0.3g | Category B | XR05CBA198X001010182068 | NHSA |
| Beijing Yi Jia Xin Chuang Medical Devices Technology Research Institute Co., Ltd. romanized | 国药准字H20213746 | 100ml:0.6g | Category B | XR05CBA198X001010182209 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20233442 | 100ml:0.3g | Category B | XR05CBA198X001010182338 | NHSA |
| Shandong Sheng Di Pharmaceuticals Co., Ltd. romanized | 国药准字H20213981 | 10ml:30mg | Category B | XR05CBA198X001010183086 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253390 | See source | Category B | XR05CBA198X001010183595 | NHSA |
| Chongqing Jian Neng Pharma Group Co., Ltd. romanized | 国药准字H20234664 | See source | Category B | XR05CBA198X001010183692 | NHSA |
| Beijing Yi Jia Xin Chuang Medical Devices Technology Research Institute Co., Ltd. romanized | 国药准字H20258053 | 60ml:0.36g | Category B | XR05CBA198X001010183695 | NHSA |
| Henan He Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20256234 | 100ml:0.3g | Category B | XR05CBA198X001010183926 | NHSA |
| Shanghai Yuan Su Pharmaceuticals Co., Ltd. romanized | 国药准字H20253373 | 100ml:0.3g | Category B | XR05CBA198X001010183955 | NHSA |
| Hangzhou Yuan Su Pharmaceuticals Co., Ltd. romanized | 国药准字H20233311 | 100ml:0.6g | Category B | XR05CBA198X001010184218 | NHSA |
| Anhui Hai Si Mei Pharmaceuticals Co., Ltd. romanized | 国药准字H20254360 | 100ml:0.6g | Category B | XR05CBA198X001010184459 | NHSA |
| Hubei Mei Si Chuang Pharma Co., Ltd. romanized | 国药准字H20254548 | 100ml:0.6g | Category B | XR05CBA198X001010184577 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010200151 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244945 | 100ml:0.3g | Category B | XR05CBA198X001010201503 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010201564 | NHSA |
| Sichuan Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20073944 | 100ml:0.3g | Category B | XR05CBA198X001010202132 | NHSA |
| Chongqing Jian Neng Pharma Group Co., Ltd. romanized | 国药准字H20233009 | 100ml:0.3g | Category B | XR05CBA198X001010202166 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001010202601 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001010202777 | NHSA |
| Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized | 国药准字H20263219 | 10ml:60mg | Category B | XR05CBA198X001010203004 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20083980 | 100ml:0.6g | Category B | XR05CBA198X001010203204 | NHSA |
| Ha Yao Group San Jing Pharmaceutical Co., Ltd. romanized | 国药准字H20184033 | 10ml:30mg | Category B | XR05CBA198X001010203705 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001010203804 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010204363 | NHSA |
| Zhejiang Kang En Bei Zhong Yao Co., Ltd. romanized | 国药准字H20203288 | 100ml:0.6g | Category B | XR05CBA198X001010204750 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20244718 | 5ml:30mg | Category B | XR05CBA198X001010205356 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20223724 | 100ml:0.3g | Category B | XR05CBA198X001010210349 | NHSA |
| Bright Future Pharmaceuticals Factory | 国药准字HC20170012 | 10ml:30mg | Category B | XR05CBA198X001010279136 | NHSA |
| Shandong Sheng Di Pharmaceuticals Co., Ltd. romanized | 国药准字H20213981 | 10ml:30mg | Category B | XR05CBA198X001010283086 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253390 | See source | Category B | XR05CBA198X001010283595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010300151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010301564 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001010302601 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001010302777 | NHSA |
| Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized | 国药准字H20263219 | 10ml:60mg | Category B | XR05CBA198X001010303004 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001010303804 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010304363 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20244718 | 5ml:30mg | Category B | XR05CBA198X001010305356 | NHSA |
| Bright Future Pharmaceuticals Factory | 国药准字HC20170012 | 10ml:30mg | Category B | XR05CBA198X001010379136 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253390 | See source | Category B | XR05CBA198X001010383595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010400151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010401564 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001010402777 | NHSA |
| Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized | 国药准字H20263219 | 10ml:60mg | Category B | XR05CBA198X001010403004 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223119 | 5ml:15mg | Category B | XR05CBA198X001010403804 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010404363 | NHSA |
| Ao Mei Pharmaceutical Factory romanized | 国药准字HC20170011 | 10ml:30mg | Category B | XR05CBA198X001010479136 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253390 | See source | Category B | XR05CBA198X001010483595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010500151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010501564 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223119 | 5ml:15mg | Category B | XR05CBA198X001010503804 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010504363 | NHSA |
| Bright Future Pharmaceuticals Factory | 国药准字HC20170012 | 10ml:30mg | Category B | XR05CBA198X001010579136 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010600151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010601564 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010604363 | NHSA |
| Ao Mei Pharmaceutical Factory romanized | 国药准字HC20170011 | 10ml:30mg | Category B | XR05CBA198X001010679136 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010700151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010701564 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010704363 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010800151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010801564 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010804363 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263317 | 5ml:30mg | Category B | XR05CBA198X001010900151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001010901564 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001010904363 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001011004363 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001011104363 | NHSA |
| Guangdong Wen Jian Pharma Co., Ltd. romanized | 国药准字H20234302 | See source | Category B | XR05CBA198X001011204363 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020100151 | NHSA |
| Guangdong Zhong Sheng Pharma Co., Ltd. romanized | 国药准字H20256279 | 100ml∶0.3g | Category B | XR05CBA198X001020100371 | NHSA |
| Guo Yao Group Shan Tou Jin Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20059208 | 10ml:30mg | Category B | XR05CBA198X001020100480 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20103285 | 0.6g/100ml | Category B | XR05CBA198X001020100555 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001020100801 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001020101442 | NHSA |
| Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 国药准字H20064090 | 100ml:0.6g | Category B | XR05CBA198X001020101445 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244946 | 100ml:0.6g | Category B | XR05CBA198X001020101503 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020101564 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001020101740 | NHSA |
| Sichuan Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20153066 | 10ml:30mg | Category B | XR05CBA198X001020102132 | NHSA |
| Sichuan Jian Neng Pharmaceutical Co., Ltd. romanized | 国药准字H20113184 | 100ml:0.6g(0.6%) | Category B | XR05CBA198X001020102166 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001020102601 | NHSA |
| Le Sheng Pharma Shijiazhuang Co., Ltd. romanized | 国药准字H20084176 | 100ml:0.6g | Category B | XR05CBA198X001020102680 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20066296 | 10ml:30mg | Category B | XR05CBA198X001020102777 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20083980 | 100ml:0.6g | Category B | XR05CBA198X001020103204 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001020103658 | NHSA |
| Ha Yao Group San Jing Pharmaceutical Co., Ltd. romanized | 国药准字H20184128 | 5ml:15mg | Category B | XR05CBA198X001020103705 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001020103804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001020104193 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001020104434 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020105038 | NHSA |
| Hua Run San Jiu (Nanchang) Pharma Co., Ltd. romanized | 国药准字H20103009 | See source | Category B | XR05CBA198X001020105342 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20264448 | 250ml:1.5g | Category B | XR05CBA198X001020105816 | NHSA |
| A. Nattermann & Cie. GmbH | 国药准字HJ20250025 | 100ml∶0.6g | Category B | XR05CBA198X001020178179 | NHSA |
| Jiangsu Su Zhong Pharma Group Biopharmaceutical Co., Ltd. romanized | 国药准字H20255825 | 100ml:0.6g | Category B | XR05CBA198X001020181821 | NHSA |
| Jiangsu Bei Jia Pharmaceutical Co., Ltd. romanized | 国药准字H20244741 | 100ml:0.6g | Category B | XR05CBA198X001020182068 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20258036 | 10ml:30mg | Category B | XR05CBA198X001020182338 | NHSA |
| Shandong Sheng Di Pharmaceuticals Co., Ltd. romanized | 国药准字H20223326 | 100ml:0.3g | Category B | XR05CBA198X001020183086 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253391 | See source | Category B | XR05CBA198X001020183595 | NHSA |
| Henan He Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20256233 | 100ml:0.6g | Category B | XR05CBA198X001020183926 | NHSA |
| Hangzhou Yuan Su Pharmaceuticals Co., Ltd. romanized | 国药准字H20233311 | 100ml:0.6g | Category B | XR05CBA198X001020184218 | NHSA |
| Anhui Hai Si Mei Pharmaceuticals Co., Ltd. romanized | 国药准字H20249794 | See source | Category B | XR05CBA198X001020184459 | NHSA |
| Hubei Mei Si Chuang Pharma Co., Ltd. romanized | 国药准字H20254549 | 100ml:0.3g | Category B | XR05CBA198X001020184577 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020200151 | NHSA |
| Guo Yao Group Shan Tou Jin Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20059208 | 10ml:30mg | Category B | XR05CBA198X001020200480 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001020200801 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020201564 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001020201740 | NHSA |
| Sichuan Da Zhong Pharmaceutical Co., Ltd. romanized | 国药准字H20153066 | 10ml:30mg | Category B | XR05CBA198X001020202132 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20066296 | 10ml:30mg | Category B | XR05CBA198X001020202777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020203647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001020203658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001020203804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001020204193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020205038 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253391 | See source | Category B | XR05CBA198X001020283595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020300151 | NHSA |
| Guo Yao Group Shan Tou Jin Shi Pharmaceutical Co., Ltd. romanized | 国药准字H20059208 | 10ml:30mg | Category B | XR05CBA198X001020300480 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001020300801 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020301564 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20066296 | 10ml:30mg | Category B | XR05CBA198X001020302777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020303647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001020303658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001020303804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001020304193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020305038 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253391 | See source | Category B | XR05CBA198X001020383595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020400151 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001020400801 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020401564 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20066296 | 10ml:30mg | Category B | XR05CBA198X001020402777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020403647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001020403658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223118 | 10ml:30mg | Category B | XR05CBA198X001020403804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001020404193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020405038 | NHSA |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20253391 | See source | Category B | XR05CBA198X001020483595 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020500151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020501564 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20066296 | 10ml:30mg | Category B | XR05CBA198X001020502777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020503647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001020503658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223118 | 10ml:30mg | Category B | XR05CBA198X001020503804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001020504193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020505038 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263318 | 10ml:30mg | Category B | XR05CBA198X001020600151 | NHSA |
| Guangdong Jiu Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20203139 | 10ml:30mg | Category B | XR05CBA198X001020601564 | NHSA |
| Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20264093 | 10ml:30mg | Category B | XR05CBA198X001020602777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020603647 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001020603804 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020605038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020703647 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020705038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020803647 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020805038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001020903647 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001020905038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001021003647 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001021005038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001021103647 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001021105038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001021203647 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263319 | 5ml:15mg | Category B | XR05CBA198X001030100151 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20103285 | 0.6g/100ml | Category B | XR05CBA198X001030100555 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001030100801 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001030101442 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001030101740 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001030102601 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001030102777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001030103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001030103658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010535 | 20ml:60mg;60ml:180mg;100ml:300mg | Category B | XR05CBA198X001030103804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001030104193 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001030104434 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001030105038 | NHSA |
| Hua Run San Jiu (Nanchang) Pharma Co., Ltd. romanized | 国药准字H20103009 | See source | Category B | XR05CBA198X001030105342 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20264445 | 100ml:0.6g | Category B | XR05CBA198X001030105816 | NHSA |
| Chengdu Bei Te De Nuo Pharma Co., Ltd. romanized | 国药准字H20258037 | 5ml:15mg | Category B | XR05CBA198X001030182338 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263319 | 5ml:15mg | Category B | XR05CBA198X001030200151 | NHSA |
| Shanghai Xin Yi Jin Zhu Pharma Co., Ltd. romanized | 国药准字H20057982 | 3mg/ml | Category B | XR05CBA198X001030200801 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001030201442 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001030204193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001030205038 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263319 | 5ml:15mg | Category B | XR05CBA198X001030300151 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001030301442 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001030304193 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001030305038 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263319 | 5ml:15mg | Category B | XR05CBA198X001030400151 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001030502777 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20093261 | 10ml:60mg(0.6%) | Category B | XR05CBA198X001030602777 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031205038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031305038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031405038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031505038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031605038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031705038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031805038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001031905038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001032005038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001032105038 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001032205038 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263320 | 2.5ml:7.5mg | Category B | XR05CBA198X001040100151 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20103285 | 0.6g/100ml | Category B | XR05CBA198X001040100555 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001040101740 | NHSA |
| Kui Hua Pharma Group (Ji Zhou) Co., Ltd. romanized | 国药准字H20093039 | 10ml:30mg | Category B | XR05CBA198X001040102601 | NHSA |
| Shi Yao Group Zhong Nuo Pharma (Shijiazhuang) Co., Ltd. romanized | 国药准字H20264094 | 10ml:60mg | Category B | XR05CBA198X001040102777 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040103647 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010534 | 5ml:15mg;10ml:30mg | Category B | XR05CBA198X001040103804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001040104193 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001040104434 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001040105038 | NHSA |
| Hua Run San Jiu (Nanchang) Pharma Co., Ltd. romanized | 国药准字H20103009 | See source | Category B | XR05CBA198X001040105342 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20264446 | 200ml:1.2g | Category B | XR05CBA198X001040105816 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263320 | 2.5ml:7.5mg | Category B | XR05CBA198X001040200151 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040203647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001040203658 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263320 | 2.5ml:7.5mg | Category B | XR05CBA198X001040300151 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040303647 | NHSA |
| Beijing Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | 国药准字H20263320 | 2.5ml:7.5mg | Category B | XR05CBA198X001040400151 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040403647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040503647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040603647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040703647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040803647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001040903647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001041003647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001041103647 | NHSA |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20103285 | 0.6g/100ml | Category B | XR05CBA198X001050100555 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001050101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001050103647 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20010535 | 20ml:60mg;60ml:180mg;100ml:300mg | Category B | XR05CBA198X001050103804 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001050104193 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001050104434 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001050105038 | NHSA |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | 国药准字H20264444 | 100ml:0.3g | Category B | XR05CBA198X001050105816 | NHSA |
| Shandong Yi Kang Pharma Co., Ltd. romanized | 国药准字H20065840 | 0.3% | Category B | XR05CBA198X001050204193 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001060101442 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001060101740 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001060103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001060103658 | NHSA |
| Shanghai Hai Hong Industrial (Group) Chao Hu Jin Chen Pharma Co., Ltd. romanized | 国药准字H20067625 | See source | Category B | XR05CBA198X001060104434 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001060105038 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001070101442 | NHSA |
| Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | 国药准字H20000281 | 100ml:0.3g | Category B | XR05CBA198X001070101740 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001070103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001070103658 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223122 | 100ml:0.3g | Category B | XR05CBA198X001070103804 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001070105038 | NHSA |
| Heilongjiang Zhong Gui Pharmaceutical Co., Ltd. romanized | 国药准字H20223122 | 100ml:0.3g | Category B | XR05CBA198X001070203804 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001080101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001080103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001080103658 | NHSA |
| Yue Yang Xin Hua Da Pharmaceutical Co., Ltd. romanized | 国药准字H20153105 | 10ml:30mg | Category B | XR05CBA198X001080105038 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001080203647 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001080303647 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001090101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001090103647 | NHSA |
| Haerbin Ren Huang Pharma Co., Ltd. romanized | 国药准字H20067008 | 5ml:15mg | Category B | XR05CBA198X001090103658 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001090201442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001100101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001100103647 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001110101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001110103647 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001120101442 | NHSA |
| Hainan Xin Hong Xing Mai Pharma Co., Ltd. romanized | 国药准字H20093973 | 0.3% | Category B | XR05CBA198X001120103647 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001130101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001140101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001150101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001160101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001170101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001180101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001180201442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001190101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20066523 | See source | Category B | XR05CBA198X001200101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001210101442 | NHSA |
| Jiangsu Han Chen Pharma Co., Ltd. romanized | 国药准字H20103641 | See source | Category B | XR05CBA198X001220101442 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20269250 | 5ml:15mg | Category B | XR05CBA198X001010183033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20269250 | 5ml:15mg | Category B | XR05CBA198X001010283033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20269249 | 10ml:30mg | Category B | XR05CBA198X001020183033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20269249 | 10ml:30mg | Category B | XR05CBA198X001020283033 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 46 filings and 29 distinct first applicants.
Generic 31 · Supplement 11 · Import re-registration 2 · Import 2
New generic filings in 2026
Loaded records: 17 filings and 12 distinct first applicants.
API registrations
Non-component matches: 25 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 盐酸氨溴索 · No verified English name | Shandong Chen Long Pharma Co., Ltd. romanized | Y20260000314 | I | Exact ingredient | 2026/04/20 | CDE |
| 盐酸氨溴索 · No verified English name | Yun Peng Pharmaceuticals Group Co., Ltd. romanized | Y20240001441 | A | Exact ingredient | 2026/04/21 | CDE |
| 盐酸氨溴索 · No verified English name | Shandong Ji Kun Biopharmaceutical Co., Ltd. romanized | Y20240001128 | A | Exact ingredient | 2026/01/16 | CDE |
| 盐酸氨溴索 · No verified English name | Hebei Guo Long Pharmaceutical Co., Ltd. romanized | Y20240000619 | A | Exact ingredient | 2026/01/06 | CDE |
| 盐酸氨溴索 · No verified English name | Shaanxi Xi Yue Pharmaceutical (Fu Feng) Co., Ltd. romanized | Y20240000334 | A | Exact ingredient | 2026/09/23 | CDE |
| 盐酸氨溴索 · No verified English name | Liao Yuan Shi Yin Ying Pharmaceutical Co., Ltd. romanized | Y20220000350 | A | Exact ingredient | 2024/04/25 | CDE |
| 盐酸氨溴索 · No verified English name | Anuh Pharma Ltd. | Y20210001017 | A | Exact ingredient | 2024/09/18 | CDE |
| 盐酸氨溴索 · No verified English name | Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | Y20190009611 | A | Exact ingredient | 2025/07/10 | CDE |
| 盐酸氨溴索 · No verified English name | Shaanxi Han Jiang Pharma Group Co., Ltd. romanized | Y20190009557 | A | Exact ingredient | 2023/04/02 | CDE |
| 盐酸氨溴索 · No verified English name | Shandong Luo Xin Pharma Group Heng Xin Pharma Co., Ltd. romanized | Y20190009400 | A | Exact ingredient | 2024/11/22 | CDE |
| 盐酸氨溴索 · No verified English name | Shilpa Pharma Lifesciences Limited | Y20190009245 | A | Exact ingredient | 2023/05/15 | CDE |
| 盐酸氨溴索 · No verified English name | Hwail Pharm.Co.,Ltd. | Y20190009124 | A | Exact ingredient | — | CDE |
| 盐酸氨溴索 · No verified English name | Bidachem S.p.A. | Y20190009079 | A | Exact ingredient | — | CDE |
| 盐酸氨溴索 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20190007190 | A | Exact ingredient | — | CDE |
| 盐酸氨溴索 · No verified English name | Chongqing Xi Nan He Cheng Pharmaceutical Co., Ltd. romanized | Y20190007025 | A | Exact ingredient | — | CDE |
| 盐酸氨溴索 · No verified English name | Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | Y20190004556 | A | Exact ingredient | 2025/07/23 | CDE |
| 盐酸氨溴索 · No verified English name | Beijing Tai Yang Pharma Co., Ltd. romanized | Y20190004137 | A | Exact ingredient | 2026/09/09 | CDE |
| 盐酸氨溴索 · No verified English name | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | Y20190004018 | A | Exact ingredient | 2025/06/13 | CDE |
| 盐酸氨溴索（供注射） · No verified English name | Shaanxi Han Jiang Pharma Group Co., Ltd. romanized | Y20180000822 | I | Exact ingredient | 2019/06/10 | CDE |
| 盐酸氨溴索 · No verified English name | Sichuan Mei Da Kang Hua Kang Pharma Co., Ltd. romanized | Y20180001754 | A | Exact ingredient | 2023/12/29 | CDE |
| 盐酸氨溴索 · No verified English name | Yang Zhou Shi San Yao Pharmaceutical Co., Ltd. romanized | Y20180000028 | I | Exact ingredient | 2019/02/18 | CDE |
| 盐酸氨溴索 · No verified English name | Shaanxi Han Jiang Pharma Group Co., Ltd. romanized | Y20180000233 | I | Exact ingredient | 2019/01/14 | CDE |
| 盐酸氨溴索 · No verified English name | Shandong Yi Kang Pharma Co., Ltd. romanized | Y20170001667 | A | Exact ingredient | 2023/12/05 | CDE |
| 盐酸氨溴索 · No verified English name | Zhejiang Zhe Bang Pharmaceutical Co., Ltd. romanized | Y20170001379 | A | Exact ingredient | 2025/06/12 | CDE |
| 盐酸氨溴索 · No verified English name | VEN PETROCHEM & PHARMA (INDIA) PVT LTD. | Y20170001137 | A | Exact ingredient | 2024/04/19 | CDE |
| 盐酸氨溴索 · No verified English name | Shanghai Xian Dai Ha Sen (Shang Qiu) Pharma Co., Ltd. romanized | Y20170000917 | A | Exact ingredient | 2026/01/01 | CDE |
| 盐酸氨溴索 · No verified English name | Tong Liao Shi Hua Bang Pharma Co., Ltd. romanized | Y20170000892 | A | Exact ingredient | 2024/10/10 | CDE |
| 盐酸氨溴索 · No verified English name | Shandong Fang Ming Pharma Group Co., Ltd. romanized | Y20170000729 | A | Exact ingredient | 2024/04/18 | CDE |
| 盐酸氨溴索 · No verified English name | Ami Lifesciences Private Limited | Y20170000627 | A | Exact ingredient | 2026/05/20 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/09Accepted
Yun Peng Pharmaceuticals Group Co., Ltd. romanized
CYHS2602757
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/10/13Accepted
Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized
CYHB2601882
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized
CYHB2601881
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
Bai Yun Shan Tang Yin Dong Tai Pharma Co., Ltd. romanized
CYHB2601880
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/12Accepted
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED; Bright Future Pharmaceuticals Factory
JYHZ2600265
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ -
2026/10/12Accepted
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED; Bright Future Pharmaceuticals Factory
JYHZ2600264
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ -
2026/09/09Accepted
Shandong Innovation Drug Research and Development Co., Ltd. romanized; Jiangxi Shimei Pharmaceutical Co., Ltd
CYHS2602249
Fact date: 2026/09/09 · Site observation date: 2026/10/22
View source ↗ -
2026/09/09Accepted
Shandong Innovation Drug Research and Development Co., Ltd. romanized; Jiangxi Shimei Pharmaceutical Co., Ltd
CYHS2602248
Fact date: 2026/09/09 · Site observation date: 2026/10/22
View source ↗ -
2026/08/25Accepted
Shandong Lu Kang Hao Li You Bio Technology Kai Fa Co., Ltd. romanized; Shaanxi Bo Sen Biopharmaceutical Shareholding Group Co., Ltd. romanized
CYHB2601505
Fact date: 2026/08/25 · Site observation date: 2026/10/21
View source ↗ -
2026/08/18Accepted
BRIGHT FUTURE PHARMACEUTICAL CO. LIMITED; BRIGHT FUTURE PHARMACEUTICALS FACTORY
JYHS2600017
Fact date: 2026/08/18 · Site observation date: 2026/10/22
View source ↗ -
2026/08/18Accepted
BRIGHT FUTURE PHARMACEUTICAL CO. LIMITED; BRIGHT FUTURE PHARMACEUTICALS FACTORY
JYHS2600016
Fact date: 2026/08/18 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Ambroxol Hydrochloride Oral Solution
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy